ACE inhibitors prevent aspiration pneumonia in Asian, but not Caucasian, elderly patients with stroke [5]

European Respiratory Journal

Volumn 29, Issue 1, 2007, Pages 218-219

  Teramoto, S ^a   Yamamoto, H ^a   Yamaguchi, Y ^a   Hanaoka, Y ^a   Ishii, M ^a   Hibi, S ^a   Ouchi, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

ASIAN; ASPIRATION PNEUMONIA; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; DISEASE PREDISPOSITION; DRUG MECHANISM; DYSPHAGIA; ELDERLY CARE; ETHNIC DIFFERENCE; EVIDENCE BASED MEDICINE; FRAIL ELDERLY; GERIATRIC PATIENT; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; RECURRENT DISEASE; RISK REDUCTION;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASIAN CONTINENTAL ANCESTRY GROUP; CEREBROVASCULAR ACCIDENT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FRAIL ELDERLY; HUMANS; PNEUMONIA, ASPIRATION;

EID: 33846200769     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00115106     Document Type: Letter

References (12)

1. van de Garde EM, Souverein PC, van den Bosch JM, Deneer VH, Leufkens HG. Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. Eur Respir J 2006; 27: 1217-1222.
2. Sekizawa K, Matsui T, Nakagawa T, Nakayama K, Sasaki H. ACE inhibitors and pneumonia. Lancet 1998; 352: 1069.
3. Arai T, Yasuda Y, Toshima S, Yoshimi N, Kashiki Y. ACE inhibitors and pneumonia in elderly people. Lancet 1998; 352: 1937-1938.
4. Teramoto S, Ouchi Y. ACE inhibitors and prevention of aspiration pneumonia in elderly hypertensives. Lancet 1999; 353: 843.
5. Ohkubo T, Chapman N, Neal B, Woodward M, Omae T, Chalmers J. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med 2004; 169: 1041-1045.
6. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; 1: 671-674.
7. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137: 977-988.
8. Etminan M, Zhang B, Fitzgerald M, Brophy JM. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study. Pharmacotherapy 2006; 26: 479-482.
9. Teramoto S, Ishii T, Yamamoto H, et al. Significance of chronic cough as a defence mechanism or a symptom in elderly patients with aspiration and aspiration pneumonia. Eur Respir J 2005; 25: 210-211.
10. Teramoto S, Matsuse T, Fukuchi Y, Ouchi Y. Simple two-step swallowing provocation test for elderly patients with aspiration pneumonia. Lancet 1999; 353: 1243.
11. Teramoto S, Ishii T, Yamamoto H, Yamaguchi Y, Ouchi Y. Nasogastric tube feeding is a cause of aspiration pneumonia in ventilated patients. Eur Respir J 2006; 27: 436-437.
12. Teramoto S, Kume H, Fukuchi Y. Antihypertensive drugs in Japan. Lancet 2001; 357: 720-721.